
Michael Cherny
Stock Analyst at Leerink Partners
(4.37)
# 1,285
Out of 5,184 analysts
558
Total ratings
58%
Success rate
5.7%
Average return
Main Sectors:
Stocks Rated by Michael Cherny
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Reiterated: Buy | $104 | $80.84 | +28.65% | 69 | Nov 19, 2026 | |
| HSIC Henry Schein | Reiterated: Hold | $92 | $83.52 | +10.15% | 34 | Nov 17, 2026 | |
| HIMS Hims & Hers Health | Reiterated: Hold | $24 | $14.60 | +64.38% | 33 | Nov 10, 2026 | |
| CERT Certara | Reiterated: Buy | $8 → $13 | $10.55 | +23.22% | 17 | Nov 5, 2026 | |
| MDLN Medline | Reiterated: Buy | $43 → $46 | $37.04 | +24.19% | 8 | Nov 5, 2026 | |
| NVST Envista Holdings | Reiterated: Buy | $32 | $22.91 | +39.68% | 27 | Nov 5, 2026 | |
| PGNY Progyny | Reiterated: Buy | $37 → $38 | $35.71 | +6.41% | 39 | Nov 5, 2026 | |
| ALGN Align Technology | Reiterated: Buy | $215 → $210 | $155.17 | +35.34% | 22 | Oct 29, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Hold | $145 → $220 | $186.71 | +17.83% | 18 | Oct 29, 2026 | |
| LH Labcorp Holdings | Reiterated: Buy | $410 | $367.13 | +11.68% | 16 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $8.29 | +20.63% | 35 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 → $292 | $272.81 | +7.03% | 39 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.92 | +71.23% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $490 → $620 | $610.54 | +1.55% | 7 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $79 → $25 | $28.73 | -12.98% | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $43 | $26.52 | +62.14% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $232 → $256 | $245.82 | +4.14% | 16 | Dec 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $203 → $210 | $258.28 | n/a | 18 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $349 → $361 | $339.09 | n/a | 37 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,069.43 | n/a | 45 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $7.45 | n/a | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $542 | $515.02 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $145.43 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.96 | n/a | 1 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.10 | n/a | 16 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $10.75 | n/a | 1 | Jan 5, 2022 |
CVS Health
Nov 19, 2026
Reiterated: Buy
Price Target: $104
Current: $80.84
Upside: +28.65%
Henry Schein
Nov 17, 2026
Reiterated: Hold
Price Target: $92
Current: $83.52
Upside: +10.15%
Hims & Hers Health
Nov 10, 2026
Reiterated: Hold
Price Target: $24
Current: $14.60
Upside: +64.38%
Certara
Nov 5, 2026
Reiterated: Buy
Price Target: $8 → $13
Current: $10.55
Upside: +23.22%
Medline
Nov 5, 2026
Reiterated: Buy
Price Target: $43 → $46
Current: $37.04
Upside: +24.19%
Envista Holdings
Nov 5, 2026
Reiterated: Buy
Price Target: $32
Current: $22.91
Upside: +39.68%
Progyny
Nov 5, 2026
Reiterated: Buy
Price Target: $37 → $38
Current: $35.71
Upside: +6.41%
Align Technology
Oct 29, 2026
Reiterated: Buy
Price Target: $215 → $210
Current: $155.17
Upside: +35.34%
ICON Public Limited Company
Oct 29, 2026
Reiterated: Hold
Price Target: $145 → $220
Current: $186.71
Upside: +17.83%
Labcorp Holdings
Oct 29, 2026
Reiterated: Buy
Price Target: $410
Current: $367.13
Upside: +11.68%
Oct 14, 2026
Reiterated: Hold
Price Target: $10
Current: $8.29
Upside: +20.63%
Aug 11, 2026
Reiterated: Buy
Price Target: $240 → $292
Current: $272.81
Upside: +7.03%
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $2.92
Upside: +71.23%
Jul 23, 2026
Reiterated: Hold
Price Target: $490 → $620
Current: $610.54
Upside: +1.55%
May 15, 2026
Rated: Buy
Price Target: $79 → $25
Current: $28.73
Upside: -12.98%
Feb 2, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $26.52
Upside: +62.14%
Dec 14, 2025
Reiterated: Buy
Price Target: $232 → $256
Current: $245.82
Upside: +4.14%
Oct 22, 2025
Reiterated: Buy
Price Target: $203 → $210
Current: $258.28
Upside: n/a
Oct 6, 2025
Reiterated: Buy
Price Target: $349 → $361
Current: $339.09
Upside: n/a
Oct 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $1,069.43
Upside: n/a
Jul 30, 2025
Reiterated: Hold
Price Target: $7.5
Current: $7.45
Upside: n/a
Dec 20, 2024
Reiterated: Buy
Price Target: $542
Current: $515.02
Upside: n/a
Sep 4, 2024
Reiterated: Hold
Price Target: n/a
Current: $145.43
Upside: n/a
Jul 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $0.96
Upside: n/a
Jun 14, 2023
Reiterated: Buy
Price Target: $22
Current: $5.10
Upside: n/a
Jan 5, 2022
Reiterated: Hold
Price Target: $7.5
Current: $10.75
Upside: n/a